Innovating Works

GlycoMar

Desconocido
Fucoderm: An effective side effect free topical emollient treatment for atopic dermatitis made from a sustain... GLYCOMAR LIMITED tramitó un H2020: H2020-SMEInst-2016-2017 Atopic dermatitis (AD), a chronic inflammatory skin disease characterised by itchy skin lesions and rashes, affects 1 child in 5-10, and 3%...
2016-12-06 - 2017-03-31 | Financiado
BEADS: Bio engineered micro Encapsulation of Active agents Delivered to Shellfish The project aims to continue with some exciting work following up a development in delivering active agents to bivalve molluscs through micr...
Financiado
BEST-STEM CELLS: Biochemically Equivalent Substitutive Technology for Stem Cells GLYCOMAR LIMITED participó en un FP7: Current technology to control embryonic and adult stem cell behaviour is dependent on conventional in vitro culture systems and crude factor...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.